S-Ventures PLC Correction: Exercise of Options (0010D)

TIDMSVEN

RNS Number : 0010D

S-Ventures PLC

14 October 2022

14 October 2022

S-VENTURES PLC

("S-Ventures" or the "Company")

Correction: Exercise of Options

The following amendment has been made to the "Exercise of Options" announcement released on 11 October 2022 at 07:00 under RNS No. 4050C.

The original announcement incorrectly stated that S-Ventures holds 122,714,545 Ordinary Shares in treasury when it should have stated 125,571,687 Ordinary Shares are held in treasury.

All other details remain unchanged. The full amended text is shown below.

The Company announces that it has received a Notice of Exercise from an option holder in respect of 268,746 options over shares at a price of 9p per ordinary share.

Application has been made for the 268,746 new ordinary shares to be admitted to trading on AQSE which is expected to occur on, or around, 14 October 2022 ("Admission").

Following the issue and admission of the new ordinary shares, the issued share capital of the Company is now 125,571,687 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interests in, or change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

 
 The Company 
  Robert Hewitt (Chief Financial 
  Officer) 
  Scott Livingston (Chief Executive 
  Officer)                             [phone] 
 
 AQSE Corporate Adviser and 
  Broker: 
  VSA Capital Limited 
  Andrew Raca - Corporate Finance 
  Andrew Monk - Corporate Broking      [phone] 
                                      --------------------- 
 
 IFC Advisory (Financial PR) 
  Graham Herring 
  Tim Metcalfe 
  Florence Chandler                    [phone] 
                                      --------------------- 
 

About S-Ventures

S-Ventures is listed on UK AQUIS Exchange (Ticker Code "SVEN"). The Company seeks to identify investment opportunities in the health & wellness, organic food and wellbeing sectors within the UK and Europe, adding value by providing capital and expertise to the target companies. The experience and operational skills of the Board led by Scott Livingston (CEO) are intended to act as an accelerator to smaller brands that have a solid foundation and platform but may lack the skills and capital. The main objectives are to cross-fertilise opportunities between the target companies and scale the individual entities and look for exit opportunities and/or synergistic collaborations through scaling we seek to create significant value for all stakeholders. Since listing on AQSE in September 2020, the Company has acquired significant interests in seven companies.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXBUBDGXSBDGDS

(END) Dow Jones Newswires

October 14, 2022 11:58 ET (15:58 GMT)